Elly Lee

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

TRAILBLAZER‐ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease

Stephen Salloway, Andrew Pain, Elly Lee et al. · Alzheimer s & Dementia · 2025 · 21 citations · Full text

Medicine, Neurology, Pharmacology +17

TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease

Stephen Salloway, Elly Lee, Michelle Papka et al. · BJPsych Open · 2023 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17